|

DM001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Xadcera Biopharmaceutical (Suzhou) Co., Ltd.1

Indications

  • Solid Carcinoma1
  • Carcinoma, Non-Small-Cell Lung1
  • Breast Neoplasms1
  • Lung Cancer1
  • Breast Cancer1

Nashville, Tennessee1 trial

A Study of DM001 in Patients With Advanced Solid Tumors

Sarah Cannon Research Institute (SCRI)

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.